Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/MAAT-PHARMA-128358114/news/MaaT-Pharma-SA-gibt-bekannt-dass-die-laufende-Phase-2B-Studie-mit-dem-Namen-Phoebus-zur-Bewertung-v-45477337/?utm_source=whatsapp&utm_medium=social&utm_campaign=share